The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | Sirard Cynthia | Chief Medical Officer | Option exercise(M) | 23K | — | — |
| Mar 28, 2025 | Sirard Cynthia | Chief Medical Officer | Option exercise(M) | 23K | — | $0 |
| Mar 28, 2025 | Mirabelli Christopher | Chairman of the Board, Director | Option exercise(M) | 23K | — | — |
| Mar 28, 2025 | Mirabelli Christopher | Chairman of the Board, Director | Tax withholding(F) | 7K | $0.32 | $2K |
| Mar 28, 2025 | Mirabelli Christopher | Chairman of the Board, Director | Option exercise(M) | 23K | — | $0 |
| Mar 28, 2025 | O'Mahony John Mark | Chief Manufacturing Officer | Option exercise(M) | 23K | — | — |
| Mar 28, 2025 | O'Mahony John Mark | Chief Manufacturing Officer | Option exercise(M) | 23K | — | $0 |
| Mar 28, 2025 | Lawlor Augustine | Chief Operating Officer | Tax withholding(F) | 8K | $0.32 | $2K |
| Mar 28, 2025 | Lawlor Augustine | Chief Operating Officer | Option exercise(M) | 23K | — | — |
| Mar 28, 2025 | Lawlor Augustine | Chief Operating Officer | Option exercise(M) | 23K | — | $0 |
| Mar 28, 2025 | Baum Jason | Chief Scientific Officer | Option exercise(M) | 23K | — | — |
| Mar 28, 2025 | Baum Jason | Chief Scientific Officer | Tax withholding(F) | 7K | $0.32 | $2K |
| Mar 28, 2025 | Baum Jason | Chief Scientific Officer | Option exercise(M) | 23K | — | $0 |
| Mar 28, 2025 | Granfield Christine | VP, Head of Reg Affairs/Qual | Tax withholding(F) | 7K | $0.32 | $2K |
| Mar 28, 2025 | Granfield Christine | VP, Head of Reg Affairs/Qual | Option exercise(M) | 23K | — | — |
| Mar 28, 2025 | Granfield Christine | VP, Head of Reg Affairs/Qual | Option exercise(M) | 23K | — | $0 |
| Mar 28, 2025 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.&Sec., Director | Option exercise(M) | 33K | — | — |
| Mar 28, 2025 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.&Sec., Director | Option exercise(M) | 33K | — | $0 |
| Nov 13, 2024 | Mirabelli Christopher | Chairman of the Board, Director | Option exercise(X) | 2K | $2.82 | $6K |
| Nov 13, 2024 | Mirabelli Christopher | Chairman of the Board, Director | Option exercise(X) | 2K | — | $0 |
| Nov 13, 2024 | Lawlor Augustine | Chief Operating Officer | Option exercise(X) | 2K | $2.82 | $6K |
| Nov 13, 2024 | Lawlor Augustine | Chief Operating Officer | Option exercise(X) | 2K | — | $0 |
| Nov 13, 2024 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.&Sec., Director | Option exercise(X) | 2K | $2.82 | $6K |
| Nov 13, 2024 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.&Sec., Director | Option exercise(X) | 2K | — | $0 |
| Nov 13, 2024 | Cavanaugh James H | Director | Option exercise(X) | 213 | $2.82 | $601 |
| Nov 13, 2024 | Cavanaugh James H | Director | Option exercise(X) | 213 | — | $0 |
| Oct 2, 2024 | Mashiach Nissim | Director | Grant(A) | 25K | — | $0 |
| Oct 2, 2024 | Baum Jason | Chief Scientific Officer | Grant(A) | 85K | — | $0 |
| Oct 2, 2024 | Mirabelli Christopher | Director | Grant(A) | 85K | — | $0 |
| Oct 2, 2024 | Cavanaugh James H | Director | Grant(A) | 25K | — | $0 |
| Oct 2, 2024 | Dietz Thomas John | Director | Grant(A) | 30K | — | $0 |
| Oct 2, 2024 | Lawlor Augustine | Chief Operating Officer | Grant(A) | 85K | — | $0 |
| Oct 2, 2024 | O'Mahony John Mark | Chief Manufacturing Officer | Grant(A) | 85K | — | $0 |
| Oct 2, 2024 | Li William | Director | Grant(A) | 25K | — | $0 |
| Oct 2, 2024 | Loscalzo Joseph | Director | Grant(A) | 25K | — | $0 |
| Oct 2, 2024 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Grant(A) | 170K | — | $0 |
| Oct 2, 2024 | Martin Patricia A. | Director | Grant(A) | 25K | — | $0 |
| Oct 2, 2024 | Richard Christian M | Director | Grant(A) | 25K | — | $0 |
| Oct 2, 2024 | Schilsky Richard | Director | Grant(A) | 25K | — | $0 |
| Oct 2, 2024 | Sirard Cynthia | Chief Medical Officer | Grant(A) | 85K | — | $0 |
| Oct 2, 2024 | Granfield Christine | VP, Head of Reg Affairs/Qual | Grant(A) | 85K | — | $0 |
| Jan 29, 2024 | Cavanaugh James H | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Li William | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Grant(A) | 170K | — | $0 |
| Jan 29, 2024 | Mirabelli Christopher | Chairman of the Board, Director | Grant(A) | 85K | — | $0 |
| Jan 29, 2024 | Loscalzo Joseph | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Lawlor Augustine | Chief Operating Officer | Grant(A) | 85K | — | $0 |
| Jan 29, 2024 | Martin Patricia A. | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Sirard Cynthia | Chief Medical Officer | Grant(A) | 85K | — | $0 |
| Jan 29, 2024 | O'Mahony John Mark | Chief Manufacturing Officer | Grant(A) | 85K | — | $0 |
| Jan 29, 2024 | Richard Christian M | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Baum Jason | Chief Scientific Officer | Grant(A) | 85K | — | $0 |
| Jan 29, 2024 | Granfield Christine | VP, Head of Reg Affairs/Qual | Grant(A) | 85K | — | $0 |
| Jan 29, 2024 | Schilsky Richard | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Dietz Thomas John | Director | Grant(A) | 30K | — | $0 |
| Jan 29, 2024 | Mashiach Nissim | Director | Grant(A) | 25K | — | $0 |
| Jan 26, 2024 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Option exercise(M) | 8K | — | — |
| Jan 26, 2024 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Option exercise(M) | 8K | — | $0 |
| Jan 26, 2024 | Lawlor Augustine | Chief Operating Officer | Option exercise(M) | 5K | — | — |
| Jan 26, 2024 | Lawlor Augustine | Chief Operating Officer | Option exercise(M) | 5K | — | $0 |
| Jan 26, 2024 | Sirard Cynthia | Chief Medical Officer | Option exercise(M) | 5K | — | — |
| Jan 26, 2024 | Sirard Cynthia | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Jan 26, 2024 | O'Mahony John Mark | Chief Manufacturing Officer | Option exercise(M) | 5K | — | — |
| Jan 26, 2024 | O'Mahony John Mark | Chief Manufacturing Officer | Option exercise(M) | 5K | — | $0 |
| Jan 26, 2024 | Mirabelli Christopher | Chairman of the Board, Director | Option exercise(M) | 5K | — | — |
| Jan 26, 2024 | Mirabelli Christopher | Chairman of the Board, Director | Option exercise(M) | 5K | — | $0 |
| Aug 23, 2023 | Schilsky Richard | Director | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Richard Christian M | Director | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Mashiach Nissim | Director | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Martin Patricia A. | Director | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Loscalzo Joseph | Director | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Cavanaugh James H | Director | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Dietz Thomas John | Director | Grant(A) | 18K | — | $0 |
| Aug 23, 2023 | Li William | Director | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Grant(A) | 140K | — | $0 |
| Aug 23, 2023 | Mirabelli Christopher | Chairman of the Board, Director | Grant(A) | 70K | — | $0 |
| Aug 23, 2023 | Lawlor Augustine | Chief Operating Officer | Grant(A) | 70K | — | $0 |
| Aug 23, 2023 | Sirard Cynthia | Chief Medical Officer | Grant(A) | 70K | — | $0 |
| Aug 23, 2023 | O'Mahony John Mark | Chief Manufacturing Officer | Grant(A) | 70K | — | $0 |
| Aug 23, 2023 | Baum Jason | Chief Scientific Officer | Grant(A) | 70K | — | $0 |
| Aug 23, 2023 | Granfield Christine | VP, Head of Reg Affairs/Qual | Grant(A) | 70K | — | $0 |
| Mar 31, 2023 | Lawlor Augustine | Chief Operating Officer | Grant(A) | 500K | — | $0 |
| Mar 31, 2023 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Grant(A) | 750K | — | $0 |
| Mar 31, 2023 | Mashiach Nissim | Director | Grant(A) | 150K | — | $0 |
| Mar 31, 2023 | Richard Christian M | Director | Grant(A) | 150K | — | $0 |
| Mar 31, 2023 | Martin Patricia A. | Director | Grant(A) | 150K | — | $0 |
| Mar 31, 2023 | Dietz Thomas John | Director | Grant(A) | 175K | — | $0 |
| Mar 31, 2023 | Schilsky Richard | Director | Grant(A) | 150K | — | $0 |
| Mar 31, 2023 | Cavanaugh James H | Director | Grant(A) | 150K | — | $0 |
| Mar 31, 2023 | Li William | Director | Grant(A) | 150K | — | $0 |
| Mar 31, 2023 | Loscalzo Joseph | Director | Grant(A) | 150K | — | $0 |
| Mar 31, 2023 | Granfield Christine | VP, Head of Reg Affairs/Qual | Grant(A) | 500K | — | $0 |
| Mar 31, 2023 | O'Mahony John Mark | Chief Manufacturing Officer | Grant(A) | 500K | — | $0 |
| Mar 31, 2023 | Sirard Cynthia | Chief Medical Officer | Grant(A) | 500K | — | $0 |
| Mar 31, 2023 | Mirabelli Christopher | Director | Grant(A) | 500K | — | $0 |
| Mar 17, 2023 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Option exercise(M) | 661K | — | — |
| Mar 17, 2023 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Option exercise(M) | 661K | — | $0 |
| Sep 6, 2022 | Schilsky Richard | Director | Grant(A) | 100K | — | $0 |
| Sep 1, 2022 | Mashiach Nissim | Director | Grant(A) | 25K | — | $0 |
| Sep 1, 2022 | Loscalzo Joseph | Director | Grant(A) | 25K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).